Aptah Bio
October 17, 2023
Franciscan D
Oncology
Aptah's molecule is the first and only compound that assures accurate RNA processing of multiple proteins. It works as a template for overall RNA quality control, altering the fate of diseased cells with no harmful effect on the healthy ones.
The great majority of diseases, including most age-related diseases, are NOT related to genetic mutations but rather to how the DNA is processed to produce all our proteins, the so-called RNA processing. At Aptah Bio, we developed a novel molecule targeting a fundamental element in RNA processing that regulates the production of all our proteins. If this specific element fails to work properly, it leads to the production of multiple toxic proteins, a common event in age-related diseases, such as dementia and many kinds of cancer.
Speakers
State
California
Country
United States
Website
https://www.aptah-bio.com/
CEO/Top Company Official
Rafael Bottos
Lead Product in Development
Age-related diseases:
Glioblastoma Multiforme - GBM-IDH-WT.
Age-Related Macular Degeneration - Dry.
Metabolic Dysfunction.
Neurodegenerative Diseases (FTD, ALS, AD).
Development Phase of Primary Product
Pre-Clinical